Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potential use of MEN-10755 in recurrent non-small cell lung cancer

Oct. 31, 2002

CDK1 inhibitors in early development at Aventis

Oct. 31, 2002

Aventis presents novel telomerase-inhibitory antitumor agents

Oct. 31, 2002

New modulators of nuclear hormone receptors covered by BMS patent

Oct. 31, 2002

ABI-007 trial cleared to continue

Oct. 30, 2002

Mitsubishi Pharma claims new tyrosine kinase inhibitors for cancer and other proliferative disorders

Oct. 29, 2002

NIH researchers identify novel thalidomide analogues

Oct. 29, 2002

IDM and Nemod to develop cancer immunotherapy products

Oct. 28, 2002

Antiangiogenic gene therapy enhances radiation-induced tumor vascular destruction

Oct. 28, 2002

Androgen receptor modulators prepared and tested at Ligand

Oct. 28, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...